Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05911178
NA

Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease

Sponsor: Centre Hospitalier St Anne

View on ClinicalTrials.gov

Summary

This study aims to analyse, in vivo, the interplay between microglial activation and tau pathology in Alzheimer's disease (AD) using \[18F\]-DPA-714 and \[18F\]-Ro948 tracers by Position Emission Tomography (PET), and their consequences on synaptic density using \[11C\]-UCB-J, a recent PET radioligand. By coupling advanced neuroimaging techniques in AD patients, while comparing them to controls, we will be able to study, for the first time in humans, the interaction between neuroinflammation, tau pathology, synaptic density, and their impact on AD progression. Joint analyses of peripheral immune biomarkers, carried out as a secondary objective, will further aim at defining peripheral correlates of this interplay. Overall, we aim to refine AD subgroup classification in order to improve and to refine the design of new therapeutic trials.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2023-10-18

Completion Date

2028-04-17

Last Updated

2024-06-13

Healthy Volunteers

Yes

Interventions

RADIATION

[11C]-UCB-J

PET tracer binding to "SV2A" protein, used to study synaptic vesicle density.

RADIATION

[18F]-DPA-714

PET tracer binding to "TSPO" protein, used to study microglial activation.

RADIATION

[18F]-RO-948

PET tracer binding to "tau" protein, used to study the topography of tau deposition.

RADIATION

[11C]-PiB

PET tracer binding to Aβ40 and Aβ42 fibrils and insoluble plaques containing the aforementioned Aß peptides, used to study the topography of amyloid deposition.

Locations (3)

CHU de Lille

Lille, France

GHU Saint Anne Psychiatrie & Neurosciences

Paris, France

CHU de Rouen

Rouen, France